Cleared Traditional

K093460 - COAGUCHEK XS PRO SYSTEM

K093460 is an FDA 510(k) clearance for COAGUCHEK XS PRO SYSTEM, manufactured by Roche Diagnostics. The device is a Class 2 Hematology device with product code GJS cleared through the Traditional 510(k) pathway after a 132-day FDA review.

K093460 · Roche Diagnostics · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2010
Decision
132d
Days
Class 2
Risk

K093460 is an FDA 510(k) clearance for the COAGUCHEK XS PRO SYSTEM. Classified as Test, Time, Prothrombin (product code GJS), Class II - Special Controls.

Submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on March 18, 2010 after a review of 132 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7750 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Roche Diagnostics devices

FDA 510(k) Submission Details - K093460

510(k) Number K093460 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 06, 2009
Decision Date March 18, 2010
Days to Decision 132 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
19d slower than avg
Panel avg: 113d · This submission: 132d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GJS Device Classification - Class 2, Special Controls

Product Code GJS Test, Time, Prothrombin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GJS Test, Time, Prothrombin

All 112
Devices cleared under the same product code (GJS) and FDA review panel - the closest regulatory comparables to K093460.
HEMOSIL READIPLAS TIN
K122584 · Instrumentation Laboratory CO · Mar 2013
INRATIO2 PI/NR MONITORING SYSTEM
K110212 · Alere San Diego, Inc (Formally Biosite Incorporate · May 2012
INRATIO/INRATIO2 TEST STRIPS
K092987 · Biosite Incorporated · Jun 2010
COAGUCHEK XS PLUS PST SYSTEM
K092940 · Roche Diagnostics Corp. · Mar 2010
HANDHELD BASE UNIT
K072920 · Roche Diagnostics Corp. · Jan 2008
HEMOSIL RECOMBIPLASTIN 2G
K070005 · Instrumentation Laboratory CO · Aug 2007